Endometrial cancer trials in United States
199 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- Where
- Aurora, Centerville, Fort Lauderdale, Hilliard, Lexington, Los Angeles, Mineola, Minneapolis, Murray, New Haven, New York, Norfolk, Oklahoma City, Peoria, Reno, Shreveport, Sioux Falls, Syracuse, Tyler, Urbana, Washington D.C., Willow Grove
- Age
- 18 years and over
- People
- 480 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06340568 · EU 2023-507525-42-00 - Phase 1Taking peopleA Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
- Where
- Beverly Hills, Boston, Canton, Dallas, Denver, Durham, Hackensack, Little Rock, Nashville, New York, Omaha, Philadelphia, Portland, Providence
- Age
- 18 years and over
- People
- 156 worldwide
- Run by
- Context Therapeutics Inc.
See details and how to joinNCT06515613 · EU 2025-523968-20-00 - Phase 3Taking peopleA Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Where
- Albuquerque, Anchorage, Bethlehem, Boston, Centerville, Chattanooga, Chicago, Cincinnati, Columbus, Covington, Durham, Eugene, Fairfax, Fort Myers, Fort Wayne, Fort Worth, Gainesville, Houston, Irvine, Jackson, Kettering, Miami Beach, Mineola, Minneapolis, Mobile, New Haven, New York, Oklahoma City, Orange, Orlando, Philadelphia, Pinehurst, Pittsburgh, Providence, Reno, Richmond, San Antonio, Savannah, Scarborough, Shreveport, Solvang, St Louis, St. Petersburg, Teaneck, Tulsa, Tyler, Walnut Creek, Washington D.C., Webster, West Palm Beach
- Age
- 18 years and over
- People
- 1,123 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06952504 · EU 2024-519331-42-00 - Phase 1/2Taking peopleA Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Where
- Ann Arbor, Baltimore, Boston, Charlottesville, Fairfax, Houston, Los Angeles, Nashville, New York, Philadelphia, Salt Lake City, Seattle, St Louis
- Age
- 18 years and over
- People
- 616 worldwide
- Run by
- Verastem, Inc.
See details and how to joinNCT07020221 - Phase 1Taking peopleA Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Where
- Austin, Celebration, Denver, Detroit, Duarte, East Brunswick, Fairfax, Fort Worth, Houston, Irvine, Irving, Lake Success, Nashville, New Haven, New York, Plantation, San Antonio, Sarasota, Spokane, West Valley City
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07503808 · EU 2026-526299-21-00 - No phaseTaking peopleImproving Rural Endometrial Cancer Care
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 50
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07927244 - Phase 2Taking peopleImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Where
- Bethesda
- Age
- 18 years to 72 years
- People
- 332
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01174121 - Phase 2Taking peopleTesting Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- Where
- Albuquerque, Anaconda, Ashland, Athens, Augusta, Battle Creek, Beachwood, Beaver, Billings, Birmingham, Boise, Bozeman, Buffalo, Butler, Caldwell, Carmel, Centerville, Chardon, Charlottesville, Chicago, Cincinnati, Cleveland, Coeur d'Alene, Columbia, Columbus, Coon Rapids, Cranberry Township, Crown Point, Dallas, Danville, Deer River, Duluth, Durham, Dyer, Edina, Edmonds, Effingham, Erie, Fargo, Farrell, Fort Worth, Fruitland, Grand Rapids, Great Falls, Greensburg, Hibbing, Hobart, Indiana, Indianapolis, Iowa City, Issaquah, Johnstown, Kalamazoo, Kalispell, Las Vegas, Louisville, Mattoon, Mayfield Heights, McKeesport, Mechanicsburg, Mentor, Meridian, Minneapolis, Missoula, Monroeville, Moon Township, Mount Pleasant, Munster, Muskegon, Nampa, Natrona Heights, New Castle, N. Huntingdon, Niles, Normal, Norton Shores, Oklahoma City, Omaha, Ontario, Parma, Pittsburgh, Portland, Post Falls, Providence, Raleigh, Reed City, Richardson, Richmond, Rochester, Saint Joseph, Saint Louis Park, Saint Paul, Sandpoint, Sandstone, Scarborough, Seattle, Seneca, Shakopee, St Louis, Syracuse, Traverse City, Tulsa, Urbana, Valparaiso, Virginia, Washington, Webster, Westlake, West Mifflin, Wyoming
- Age
- 18 years and over
- People
- 81
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05112601 - No phaseEnrolling by invitationDeveloping a Gynecologic Cancer Health Promotion Community Engagement Program
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 100
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT07910162 - Phase 3Taking peopleImpact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- Where
- Augusta, Baltimore, Bel Air, Billings, Bryn Mawr, Butte, Carmel, Charlottesville, Chicago, Coral Gables, Dallas, Deerfield Beach, Detroit, Doral, Edina, Farmington Hills, Flint, Fort Worth, Houston, Indianapolis, Kearney, Las Vegas, Maple Grove, Maplewood, Marrero, Metairie, Miami, New Orleans, North Miami, Oklahoma City, Omaha, Paoli, Plantation, Princeton, Providence, Richardson, Saint Paul, Springfield, Sugar Land, The Woodlands, Warrenville, Washington D.C., Wynnewood, Wyoming
- Age
- 18 years and over
- People
- 428 worldwide
- Run by
- NRG Oncology
See details and how to joinNCT05646316 - Phase 2Taking peopleAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Where
- Grand Forks, Jacksonville
- Age
- 18 years and over
- People
- 220
- Run by
- Mayo Clinic
See details and how to joinNCT05969860 - Phase 3Taking peopleTesting the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Where
- ‘Aiea, Albuquerque, Anaconda, Anchorage, Ankeny, Ann Arbor, Ashland, Athens, Atlanta, Augusta, Aurora, Baltimore, Basking Ridge, Battle Creek, Bay Shore, Beachwood, Bellevue, Billings, Birmingham, Boston, Bozeman, Brainerd, Brewer, Bridgeport, Brighton, Burlington, Camden, Canton, Carmichael, Carroll, Cedar Rapids, Chapel Hill, Chardon, Charleston, Charlottesville, Chelsea, Chicago, Cleveland, Clinton, Clive, Coeur d'Alene, Colorado Springs, Columbia, Columbus, Commack, Coon Rapids, Crown Point, Danville, Decatur, Deer River, DeKalb, Delaware, Des Moines, Detroit, Dublin, Duluth, Durham, Edina, Edmonds, Effingham, Elk Grove, Erie, Escanaba, Evanston, ‘Ewa Beach, Fargo, Farmington Hills, Fayetteville, Flint, Flushing, Fort Collins, Fort Dodge, Franklin, Fremont, Fresno, Geneva, Glenview, Goldsboro, Goshen, Grand Rapids, Great Falls, Greeley, Green Bay, Greenlawn, Greensburg, Harrison, Hartford, Harvey, Hershey, Hibbing, Highland Park, Highlands Ranch, Honolulu, Indianapolis, Iowa City, Issaquah, Jacksonville, Kalamazoo, Kalispell, Kearney, La Crosse, Lake Success, Lansing, Las Vegas, Lexington, Little Rock, Livingston, Livonia, Los Angeles, Loveland, Manchester, Manistique, Mansfield, Marion, Marrero, Martinsburg, Mattoon, Mechanicsburg, Mentor, Metairie, Middletown, Millville, Milwaukee, Minneapolis, Missoula, Modesto, Montvale, Morgantown, Muskegon, Nashville, Newark, New Britain, New Brunswick, New Lenox, New Orleans, New York, Niles, Normal, Norton Shores, N. Venice, Oak Brook, Oakland, Oak Park, Oconto Falls, O'Fallon, Oklahoma City, Omaha, Orland Park, Palo Alto, Paramus, Parkersburg, Parma, Peabody, Peoria, Philadelphia, Phoenix, Pickerington, Pittsburgh, Pontiac, Portland, Post Falls, Providence, Raleigh, Rancho Mirage, Reed City, Rego Park, Rehoboth Beach, Richmond, Ridgewood, Rochester, Rocklin, Rogers, Roseville, Sacramento, Saint Joseph, Saint Louis Park, Saint Paul, Salt Lake City, Sandpoint, Sandstone, San Francisco, San Jose, San Leandro, San Rafael, Santa Clara, Santa Rosa, Sarasota, Scarborough, Seattle, Sewell, Sheboygan, Sleepy Hollow, South Bend, South Jordan, South San Francisco, Spooner, Springdale, Springfield, Staten Island, St Louis, Stony Brook, Sturgeon Bay, Superior, Sylvania, Syracuse, The Bronx, Traverse City, Tualatin, Tucson, Uniondale, Urbana, Vallejo, Vancouver, Venice, Virginia, Walnut Creek, Warrenville, Washington, Washington D.C., Waukee, Webster, Westerville, Westlake, Willow Grove, Woodbury, Woodland, Wyoming, Ypsilanti
- Age
- 18 years and over
- People
- 255
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07198074 - No phaseTaking peopleLeveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Where
- Atlanta, Chicago, Cleveland, Detroit, Eau Claire, Evergreen Park, Grand Forks, Houston, Howard Beach, Jackson, Jacksonville, Katy, La Crosse, Miami, Milwaukee, New Orleans, Orlando, Pembroke Pines, Phoenix, Richmond, Rochester, Saginaw, Sarasota, Westbury
- Age
- 18 years and over
- People
- 3,110
- Run by
- Mayo Clinic
See details and how to joinNCT05051722 - Phase 1/2Taking peoplePembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06253494 - Phase 1Taking peopleA Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Where
- Atlanta, Augusta, Austin, Boston, Charlottesville, Dallas, Denver, Fairfax, Fairway, Hackensack, Lake Mary, Little Rock, Los Angeles, Nashville, Orlando, Philadelphia, Pittsburgh, Salt Lake City, San Francisco
- Age
- 19 years and over
- People
- 238 worldwide
- Run by
- NiKang Therapeutics, Inc.
See details and how to joinNCT06586957 - Phase 3Taking peopleAssessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in Endometrial Cancer
- Where
- Cary, Chapel Hill, Garner, Greensboro, Raleigh
- Age
- 18 years and over
- People
- 140
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07867002 - Phase 2Taking peopleStudy of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
- Where
- Allentown, Basking Ridge, Commack, Harrison, Hartford, Miami, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 212
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04165772 - No phaseTaking peoplecfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Where
- Austin, Charleston, Cleveland, Corbin, Duarte, Elizabethtown, Florence, Gainesville, Lexington, Memphis, Miami, Minneapolis, Nashville, New Albany, Paducah, Portland, Rochester
- Age
- 40 years and over
- People
- 7,000
- Run by
- Adela, Inc
See details and how to joinNCT05366881 - Phase 1/2Taking peopleRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Where
- Abilene, Augusta, Austin, Boston, Camden, Columbus, Dallas, Detroit, Doylestown, Eugene, Everett, Fairfax, Fort Myers, Fort Worth, Grand Rapids, Los Angeles, Maplewood, Nashville, Norfolk, Oklahoma City, Phoenix, Pittsburgh, Portland, Providence, Rockville, San Diego, Santa Barbara, Santa Rosa, St. Petersburg, Tucson, Tyler, West Palm Beach, West Valley City, Westwood, Woodland
- Age
- 18 years and over
- People
- 952 worldwide
- Run by
- Genmab
See details and how to joinNCT05579366 - Phase 1Taking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Atlanta, Columbus, Falls Church, Grand Rapids, Houston, La Jolla, Mineola, New York, Scottsdale, West Valley City
- Age
- 18 years and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - Phase 2Taking peopleA Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Where
- Amarillo, Chicago Ridge, Dallas, Detroit, Fort Myers, Horsham, Houston, Knoxville, Lake Success, Littleton, Nashville, New York, Orlando, Prescott, Roanoke, San Antonio, St. Petersburg, West Palm Beach, Westwood
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06695845 · EU 2024-516551-41-00 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Birmingham, Boston, Cleveland, Detroit, Duarte, Farmington Hills, Fort Myers, Houston, Madison, Nashville, Seattle
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - No phaseTaking peopleDistance-Based Exercise to Preserve Function and Prevent Disability
- Where
- Boston, Butler, Cranberry Township, Dublin, Fremont, Fresno, Indiana, Kernersville, Mechanicsville, Midlothian, Modesto, Mount Airy, New Castle, Oakland, Pittsburgh, Richmond, Sacramento, San Francisco, San Jose, San Rafael, Santa Clara, Santa Rosa, Seneca, Vallejo, Walnut Creek, Winston-Salem
- Age
- 18 years and over
- People
- 104
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT07059884 - Phase 1Taking peoplePhase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Where
- Canton, Charlotte, Dallas, Detroit, Durham, Fairfax, St Louis, West Valley City
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Sairopa B.V.
See details and how to joinNCT05856981 - No phaseTaking peopleMolecular and ctDNA Characterization of High-Risk Endometrial Cancer
- Where
- Rochester
- Age
- 18 years and over
- People
- 100
- Run by
- Mayo Clinic
See details and how to joinNCT07062016